American Hospital Association September 16, 2021
Stacey Hughes

A new report from the Community Oncology Alliance (COA) once again tries to obfuscate the issue of sky-rocketing drug prices by choosing to blame hospitals rather than the drug companies who set the prices and enjoy double-digit profits at the expense of patients and the providers who serve them.

One reason why drug prices can grow so much faster than other health sectors is that drug companies routinely suppress competition and are therefore able to set the prices of their drugs at any price they wish. In any other health care sector, prices and reimbursement are either competitively negotiated between different sectors or regulated by the government.

The COA report narrowly focuses on a small sample size of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Health System / Hospital, Healthcare System, Pharma, Pharma / Biotech, Physician, Pricing / Spending, Provider, Survey / Study, Trends
Health systems ramp up AI partnerships to tackle doctor burnout
Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
How physician incentive bonuses have changed over the last 5 years
Is peer coaching the solution to physician burnout?
Why independent physicians could have more power than employed counterparts: Viewpoint

Share This Article